4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001209191-21-049793
COO & CBO sold 5,700 shares at $28.87 ($164,554)
- COO & CBO acquired 5,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nash Huw M. COO & CBO | 2021-08-02 | Option exercise | +5,700 | $2.19 | $12,483 | 5,700 | D |
| Nash Huw M. COO & CBO | 2021-08-02 | Sale | −5,700 | $28.87 | $164,554 | 0 | D |
| Derivatives | |||||||
| Nash Huw M. COO & CBO | 2021-08-02 | Option exercise · Employee Stock Option (Right to Buy) | −5,700 | 113,422 | D | ||
| Open-market sales · 5,700 sh · avg $28.87 · $164,554 | |||||||
Loading xslF345X03/doc4.xml…